Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why SCYNEXIS Inc. (SCYX), Apple Inc. (AAPL) and Three Other Stocks Are in Spotlight Today

Page 1 of 2

The US stock market is trading lower amid marginal decline in crude oil prices and ahead of the Friday jobs data.

Meanwhile, a number of stocks are showing  SCYNEXIS Inc. (NASDAQ:SCYX), Apple Inc. (NASDAQ:AAPL), Metlife Inc. (NYSE:MET), Semtech Corporation (NASDAQ:SMTC) and Deutsche Bank AG (USA) (NYSE:DB). Lets take a look at the news behind these stocks and assess the hedge fund sentiment towards them.

The smart money sentiment is an important metric that can be used to assess the long-term profitability of a stock. While there are thousands of stocks trading daily on the market, taking a look at what hedge funds think about certain companies can narrow down the search significantly. At Insider Monkey, we track more than 700 hedge funds, whose 13F filings we analyze as part of our small-cap strategy. Our research has shown that imitating a portfolio that includes the 15 most popular small-cap stocks among hedge funds can outperform the market by as much as 95 basis points per month on average (see more details here).

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart


SCYNEXIS Inc. (NASDAQ:SCYX) surged by 30% in pre-market session, but has given the majority of those gains since the opening bells on the news of its Oral SCY-078 drug testing for the treatment of vulvovaginal candidiasis (VVC). For the drug’s Phase 2 studies, the company reported that one of the studies revealed significantly better clinical cure rates for the drug. It also showed lower rate of recurrence of VVC at the four-month follow-up. The second study tested the drug as a step-down therapy in patients with invasive candidiasis. In this test, the drug reached the target exposure for efficacy. Among the funds we track, 12 funds held $15.34 million worth of SCYNEXIS’s stock in aggregate at the end of June, having amassed 51.10% of its outstanding stock, compared to eight investors that held $13.35 million worth of shares a quarter earlier.

Follow Scynexis Inc (NASDAQ:SCYX)
Trade (NASDAQ:SCYX) Now!

Apple Inc. (NASDAQ:AAPL) stock is in the spotlight amid news that the tech giant is boosting its profile in cloud segment. Cloud business is increasingly becoming highly competitive with the likes of Amazon, Microsoft and Google vying for the market share. According to Bloomberg, Apple is looking to unify its various cloud-related services such as Apple Pay, Siri and Maps at its Infinite Loop campus. The number of funds from our long Apple declined to 116 from 152 during the second quarter, while the total value of their holdings decreased to $10.67 billion from $14.82 billion.

Follow Apple Inc (NASDAQ:AAPL)
Trade (NASDAQ:AAPL) Now!

On the next page, we are going to discuss the developments surrounding Metlife Inc. (NYSE:MET), Semtech Corporation (NASDAQ:SMTC), and Deutsche Bank AG (USA) (NYSE:DB).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!